Xcel Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,541
Closed -$425K 142
2021
Q4
$425K Sell
5,541
-13,335
-71% -$1.06M 0.11% 111
2021
Q3
$1.42M Buy
18,876
+3,450
+22% +$262K 0.41% 63
2021
Q2
$1.2M Sell
15,426
-2,329
-13% -$173K 0.36% 59
2021
Q1
$1.31M Buy
17,755
+9,196
+107% +$678K 0.47% 52
2020
Q4
$668K Buy
8,559
+5,862
+217% +$448K 0.29% 69
2020
Q3
$213K Buy
+2,697
New +$211K 0.11% 104

Other funds holding MRK

Xcel Wealth Management's MRK Position: Q1 2022 in Review

Xcel Wealth Management sold out of Merck (MRK) in Q1 2022, closing a stake of 5,541 shares — an estimated $425K sold.

Xcel Wealth Management first reported a position in MRK in Q3 2020 and held it in 6 quarters. The position peaked at $1.42M in Q3 2021. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Xcel Wealth Management reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Xcel Wealth Management sold 5,541 Merck shares in Q1 2022, an estimated $425K.
  • Xcel Wealth Management first reported a position in Merck in Q3 2020 and held it in 6 quarters.
  • Xcel Wealth Management's Merck position peaked at $1.42M in Q3 2021.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Xcel Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.